Intellia Therapeutics, Inc.
NTLA · In Vitro & In Vivo Diagnostic Substances7
Directors
64
Avg Age
5.4
Avg Tenure (yrs)
86%
Independent
Independent
Non-independent
Near rotation
Board Members
FM
Frank Verwiel, M.D.
Chair
BG
Brian Goff
Director
...and 5 more directors
The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.
Get Seats OpeningSource: SEC DEF 14A proxy statement filed 2026-04-30. Data extracted and structured by FindABoardSeat.